Revolutionizing localized prostate cancer treatment: Stereotactic radiotherapy "Moroccan experience".
Asmâa NaimZineb LahlouOthmane KaanouchAbdelajalil HeddatSafae MansouriPublished in: Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica (2024)
The results of our study are consistent with the existing literature and support the safety and effectiveness of SBRT as a treatment option for localized prostate cancer (CaP). In the United States, both ASTRO and the NCCN recognize SBRT as a valid treatment option for localized CaP. Ongoing phase III trials are being conducted to further substantiate these long-term results and to establish SBRT as the future standard of care for localized CaP.
Keyphrases
- prostate cancer
- radiation therapy
- phase iii
- systematic review
- healthcare
- clinical trial
- randomized controlled trial
- open label
- early stage
- palliative care
- combination therapy
- radiation induced
- small cell lung cancer
- quality improvement
- chronic pain
- double blind
- replacement therapy
- phase ii
- placebo controlled
- affordable care act